43 Results for "

Histone-lysine methyltransferase

" in MedChemExpress (MCE) Product Catalog:
Products (43)

43 Results for "Histone-lysine methyltransferase" in MCE Product Catalog:

Cat. No.: HY-12991A
CAS No.: 1228184-65-3
Purity:  98.81%
Research Areas:  

Cancer

BIX-01338 hydrate is a histone lysine methyltransferase inhibitor.
loading...
    loading...
Cat. No.: HY-114340
CAS No.: 1814881-70-3
Purity:  98.06%
Research Areas:  

Cancer

LEM-14 is a potent and selective NSD2 inhibitor with an IC50 of 132 µM. LEM-14 has very weak activitv against NSD1 and has no activity against NSD3. LEM-14 inhibits fibrotic gene expression in ND but not DIO BMDMs. LEM-14 combined with ionizing radiation (IR) enhances the apoptosis rate and reduces the colony-formation ability of CRC cells. LEM-14 exhibits enhanced anti-tumor efficacy in Balb/c nude mice bearing LoVo cell xenografts when combined with ionizing radiation. LEM-14 has the potential for the research of multiple myeloma and colorectal cancer .
loading...
    loading...
Cat. No.: HY-156285
CAS No.: 3053365-82-2
Purity:  98.74%
Research Areas:  

Cancer

ZZM-1220 is a histone lysine methyltransferase G9a/GLP covalent inhibitor with IC50s of of 458 nM and 924 nM, respectively. ZZM-1220 inhibits H3K9me2 in cells and significantly induces apoptosis of triple-negative breast cancer (TNBC) cells and blocks the cell cycle in the G2/M phase .
loading...
    loading...
Cat. No.: HY-44062
CAS No.: 1350752-07-6
Research Areas:  

Inflammation/Immunology Cancer

G9a-IN-1 (Compound 113) is a G9a protein inhibitor. G9A/EHMT2 is a nuclear histone lysine methyltransferase that catalyzes histone H3 lysine 9 dimethylation (H3K9me2), which is a reversible modification generally associated with transcriptional gene silencing. G9a-IN-1 can be used for the research of autoimmune disorders or cancer .
loading...
    loading...
Cat. No.: HY-W516880
CAS No.: 73736-50-2
Synonyms: O-Demethylastemizole
Desmethylastemizole (O-Demethylastemizole) , a metabolite of Astemizole (HY-12532), is a β-hematin (βH) inhibitor. Desmethylastemizole has an antiplasmodium activity against P. falciparum with IC50 of 0.12, 0.11 and 0.06  μM for Pf3D7, PfDd2, and PfItG strains, respectively. Desmethylastemizole is also a Histamine H1 receptor antagonist. Desmethylastemizole significantly blocks hERG K + channels and also inhibits histone-lysine N-methyltransferase EZH2 activity. Desmethylastemizole can be used for long QT syndrome and malaria research .
loading...
    loading...
Cat. No.: HY-125244
CAS No.: 2987501-17-5
Purity:  99.57%
Research Areas:  

Cancer

LEM-14-1189, a LEM-14 (HY-114340) derivative, is a NSDs inhibitor with IC50s of 418 μM (NSD1), 111 μM (NSD2), and 60 μM (NSD3), respectively. The NSDs, histone lysine methyltransferases (HMTases), are oncoproteins, drivers of a number of tumors. LEM-14-1189 can be used for multiple myeloma (MM) research .
loading...
    loading...
Cat. No.: HY-111544
CAS No.: 2328074-38-8
Research Areas:  

Cancer

EML741 is a histone lysine methyltransferase G9a/GLP inhibitor, with an IC50 of 23 nM, Kd of 1.13 μM for G9a. EML741 also inhibits DNMT1 (IC50, 3.1 μM), with no effect on DNMT3a or DNMT3b. EML741 exhibits low cell toxicity, and is membrane permeable and blood-brain barrier penetrated .
loading...
    loading...
Cat. No.: HY-10587A
CAS No.: 1808255-64-2
Research Areas:  

Cancer

BIX-01294 hydrochloride hydrate is a histone-lysine methyltransferase (HMTase) inhibitor, which selective inhibits the G9aHMTase with IC50 of 1.7 μM, reduces histone-3 lysine (9) methylation (H3K9me), induces autophagy and apoptosis in human glioma cells .
loading...
    loading...
Cat. No.: HY-P701589
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: KMT2D; Trinucleotide Repeat Containing 21; Prev. MLL2; [Histone H3]-lysine(4) N-methyltransferase; Prev. TNRC21; Histone-lysine N-methyltransferase MLL2; Histone-lysine N-methyltransferase 2D; Histone-lysine N-methyltransferase 2C; MLL4; Truncated lysine
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P701590
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: KMT2D; Trinucleotide Repeat Containing 21; Prev. MLL2; [Histone H3]-lysine(4) N-methyltransferase; Prev. TNRC21; Histone-lysine N-methyltransferase MLL2; Histone-lysine N-methyltransferase 2D; Histone-lysine N-methyltransferase 2C; MLL4; Truncated lysine
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-113786
CAS No.: 923894-97-7
Research Areas:  

Cancer

EZH2-IN-21 is a potent inhibitor of the histone lysine methyltransferase enhancer of zeste homologue 2 (EZH2) with anticancer activity. EZH2-IN-21 is competitive with the cofactor SAM and noncompetitive with peptide or nucleosome substrates .
loading...
    loading...
Cat. No.: HY-116605
CAS No.: 1346704-13-9
Research Areas:  

Cancer

GSK926 (compound 3) is a selective histone lysine methyltransferase EZH2 inhibitor (IC50=0.02 μM; Ki=7.9 nM), with SAM-competitive and cell-active properties. GSK926 can be used in cancer research .
loading...
    loading...
Cat. No.: HY-156455
Research Areas:  

Cancer

SETD7-IN-1 (compound 7) is a PFI-2 (HY-18627) analogue. SETD7-IN-1 is a substrate and inhibitor of histone lysine methyltransferase SETD7, with an IC50 of 0.96 ± 0.10 µM .
loading...
    loading...
Cat. No.: HY-P811143
Synonyms: Histone-lysine N-methyltransferase SETMAR, SET domain and mariner transposase fusion protein, Metnase, SETMAR

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-150680
CAS No.: 2816165-02-1
SARS-CoV-2 nsp14-IN-1 (Compound 3) is a prototypic bisubstrate inhibitor of SARS-CoV-2 Nsp14 MTase with an IC50 value of 0.061 μM. SARS-CoV-2 nsp14-IN-1 (Compound 3) has an excellent selectivity profile over a panel of human methyltransferases, can against apanel of 10 human MTases including histone lysine, proteinarginine, and DNA and RNA MTases .
loading...
    loading...
Cat. No.: HY-P703634
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: KMT2C; Homologous To ALR Protein; Prev. MLL3; Myeloid/Lymphoid Or Mixed-Lineage Leukemia 3; Histone-lysine N-methyltransferase 2C; [Histone H3]-lysine(4) N-methyltransferase; HALR; Histone-lysine N-methyltransferase MLL3; KIAA1506; lysine N-Methyltransfer
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P702887
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: KMT2C; Homologous To ALR Protein; Prev. MLL3; Myeloid/Lymphoid Or Mixed-Lineage Leukemia 3; Histone-lysine N-methyltransferase 2C; [Histone H3]-lysine(4) N-methyltransferase; HALR; Histone-lysine N-methyltransferase MLL3; KIAA1506; lysine N-Methyltransfer
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P80507
Synonyms: KMT6, EZH2, Histone-lysine N-methyltransferase EZH2, ENX-1, Enhancer of zeste homolog 2, lysine N-methyltransferase 6

Host:  

Rabbit

Application:  

IHC-P, ICC/IF

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P85132
Synonyms: EHMT1; EUHMTASE1; GLP; KIAA1876; KMT1D; Histone-lysine N-methyltransferase EHMT1; Euchromatic Histone-lysine N-methyltransferase 1; Eu-HMTase1; G9a-like protein 1; GLP; GLP1; Histone H3-K9 methyltransferase 5; H3-K9-HMTase 5; lysine N-methy

Host:  

Mouse

Application:  

WB, ELISA

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P76062
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: SETD7; KIAA1717; SET Domain Containing 7, Histone lysine methyltransferase; Set9; SET7/9; SET Domain Containing lysine methyltransferase 7; SET7; lysine N-methyltransferase 7; KMT7; H3-K4-HMTase SETD7; Histone-lysine N-methyltransferase SETD7; SET Domain
Species:  
Human
Source:  
E. coli
loading...
    loading...